Profiles RNS Covid Authors

Ali Elbeddini

Institution	Winchester District Memorial Hospital
Address	Canada
vCard	Download vCard

Publication Timeline

COVID-19 publications

All Publications

Bar chart showing 16 publications over 3 distinct years, with a maximum of 14 publications in 2020

These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

To see the data from both graphs as text, click here.

Year	Publications
2019	1
2020	14
2021	1

Publication Field Summary

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Publication List

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.

Show: All coronarirus related publications | Covid-19 specific publications | All publications

Sort By: Newest | Oldest | Most Cited | Most Discussed

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Elbeddini A, Almasalkhi S, Prabaharan T, Tran C, Gazarin M, Elshahawi A. Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources. J Pharm Policy Pract. 2021 Jan 19; 14(1):10. PMID: 33468248.

Citations:
Elbeddini A, Botross A, Gerochi R, Gazarin M, Elshahawi A. Pharmacy response to COVID-19: lessons learnt from Canada. J Pharm Policy Pract. 2020 Dec 09; 13(1):76. PMID: 33298184.

Citations: 3
Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract. 2020; 13:73. PMID: 33117545.

Citations: 1
Elbeddini A, To A, Tayefehchamani Y, Wen C. Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic. J Clin Mov Disord. 2020; 7:7. PMID: 32782815.

Citations: 7
Elbeddini A, Tayefehchamani Y, Yang L. Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage. Drugs Ther Perspect. 2020; 36(10):451-454. PMID: 32837193.

Citations: 3
Elbeddini A, Wen CX, Tayefehchamani Y, To A. Mental health issues impacting pharmacists during COVID-19. J Pharm Policy Pract. 2020; 13:46. PMID: 32704376.

Citations: 18
Elbeddini A, Prabaharan T, Almasalkhi S, Tran C. Pharmacists and COVID-19. J Pharm Policy Pract. 2020; 13:36. PMID: 32572350.

Citations: 21
Elbeddini A, Yeats A, Lee S. Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract. 2020; 13:30. PMID: 32537170.

Citations:
Elbeddini A, Tayefehchamani Y. Amid COVID-19 pandemic: Challenges with access to care for COPD patients. Res Social Adm Pharm. 2021 01; 17(1):1934-1937. PMID: 32513515.

Citations: 3 Fields:
Pha Pharmacy
Translation:Humans
Elbeddini A, Prabaharan T, Almasalkhi S, Tran C, Zhou Y. Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic. Res Social Adm Pharm. 2021 01; 17(1):1942-1945. PMID: 32499161.

Citations: 3 Fields:
Pha Pharmacy
Translation:Humans
Elbeddini A, Hooda N, Yang L. Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic. Can Pharm J (Ott). 2020 Jul-Aug; 153(4):198-203. PMID: 33193918.

Citations: 5
Elbeddini A, Yeats A. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract. 2020; 13:23. PMID: 32501410.

Citations: 11
Elbeddini A. Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. J Pharm Policy Pract. 2020; 13:19. PMID: 32454983.

Citations: 3
Elbeddini A, Yeats A. Amid COVID-19 drug shortages: proposed plan for reprocessing and reusing salbutamol pressurized metered dose inhalers (pMDIs) for shared use. Drugs Ther Perspect. 2020; 36(7):300-302. PMID: 32837185.

Citations: 4
Elbeddini A, Yeats A, Lee S. Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract. 2020; 13:18. PMID: 32454982.

Citations: 2